Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine vs Insulin lispro in Type 2 Diabetes
NCT00311818Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2003
- Primary completion
- May 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jun 2003; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00311818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311818.